Mobile

A clinical study in patients with complicated infections of the urinary tract conducted to assess safety, tolerability and efficacy of the study drug (MK-7655) administered together with Imipenem/Cila...

Mise à jour : Il y a 5 ans
Référence : EUCTR2011-005707-32

A clinical study in patients with complicated infections of the urinary tract conducted to assess safety, tolerability and efficacy of the study drug (MK-7655) administered together with Imipenem/Cilastatin (an antibiotic) in comparison with Imipenem/Cilastatin administered alone

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

- To evaluate the efficacy of 2 doses of MK-7655 + imipenem/cilastatin (250 mg and 125 mg) with respect to the microbiological response assessment profile in the treatment of adult patients with cUTI, as compared to imipenem/cilastatin at completion of IV study therapy (DCIV). - To evaluate the safety and tolerability profile of 2 doses of MK-7655 + imipenem/cilastatin (250 mg and 125 mg).

Critère d'inclusion

  • Patients with Complicated Urinary Tract Infection at least 18 years of age, with a diagnosis of either complicated cUTI or acute pyelonephritis

Liens